Method for treating hepatitis b carriers with minimal disease

Details Method for treating hepatitis b carriers with minimal disease Method for treating hepatitis b carriers with minimal disease

A - Human Necessities

61

K

A61K 38/22 (2006.01)

Patent

CA 2175046

Thymosin .alpha.-1, or biologically active fragments or analogs of thymosin .alpha.-1, are administered for treatment of minimal disease hepatitis B infection.

La thymosine .alpha.-1, ou des fragments ou des analogues biologiquement actifs de la thymosine .alpha.-1 sont administrés afin de traiter une infection par le virus de l'hépatite B avec état pathologique minime.

Affiliated with

Also associated with

Rating

Method for treating hepatitis b carriers with minimal disease does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for treating hepatitis b carriers with minimal disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating hepatitis b carriers with minimal disease will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1899332